Millendo Therapeutics finalizes merger with OvaScience, strengthens rare disease pipeline

pharmanewsdaily- December 9, 2018 0

Millendo Therapeutics has finalized its merger with OvaScience, a Massachusetts-based biotech firm specializing in female infertility treatments. The transaction, initially announced in August 2018, concludes ... Read More